Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

101.10 peptide

Known as: peptide 101.10, rytvela 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Novel Anti-Interleukin-1β Therapy Preserves Retinal Integrity: A Longitudinal Investigation Using OCT Imaging and Automated Retinal Segmentation in Small Rodents
Retinopathy of prematurity (ROP) is the leading cause of blindness in neonates. Inflammation, in particular interleukin-1β (IL-1… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2015
Highly Cited
2015
Novel Noncompetitive IL-1 Receptor–Biased Ligand Prevents Infection- and Inflammation-Induced Preterm Birth
Preterm birth (PTB) is firmly linked to inflammation regardless of the presence of infection. Proinflammatory cytokines… Expand
  • table I
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2015
2015
This information is current as Inflammation-Induced Preterm Birth Ligand Prevents Infection-and Biased − Novel Noncompetitive IL-1 Receptor Girard and Sylvain
Preterm birth (PTB) is firmly linked to inflammation regardless of the presence of infection. Proinflammatory cytokines… Expand
  • table I
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Highly Cited
2013
Highly Cited
2013
Microglia and Interleukin-1&bgr; in Ischemic Retinopathy Elicit Microvascular Degeneration Through Neuronal Semaphorin-3A
Objective—Proinflammatory cytokines contribute to the development of retinal vasculopathies. However, the role of these factors… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Insertion of multiple α‐amino γ‐lactam (Agl) residues into a peptide sequence by solid‐phase synthesis on synphase lanterns
The insertion of lactams into peptide analogs can enhance potency and improve receptor selectivity. The synthesis of lactam… Expand
Highly Cited
2008
Highly Cited
2008
Development of a Novel Noncompetitive Antagonist of IL-1 Receptor1
IL-1 is a major proinflammatory cytokine which interacts with the IL-1 receptor I (IL-1RI) complex, composed of IL-1RI and IL-1R… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
2008
2008
Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor.
Inflammation participates in the genesis and progression of hypoxic-ischemic brain injury. Interleukin (IL)-1 is a major pro… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE